News

Latest draft Marie Sklodowska-Curie Actions (MSCA) work programme 2023-2025 - publicly available

Published on | 2 months ago

Programmes MSCA

It is expected that the European Commission would launch by the end of this month the pre-publication of the Horizon Europe Main Work Programme (WP) 2025. In the European Commission comitology register* the latest draft (April 2025) of the Marie Sklodowska-Curie Actions (MSCA) 2023-2025 work programme is available for download. Be aware that availability of documents in the register is subject to change i.e. available for download or a request to the relevant Commission department is required.

*The comitology register contains a list of all comitology committees, as well as background information and documents relating to the work of each committee (including the Programme Committees for the differents parts of Horizon Europe) 

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1641 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.